In the News
Advocacy is an activity by an individual or group which aims to influence decisions within political, economic, and social systems and institutions.
WHAT WE ARE WORKING ON
Our Latest News: Read about
our work in action.
Lenalidomide Price Case Progress
Access to Medicine: Lenalidomide Cancer Alliance submitted a case for the investigation of excessive pricing for lenalidomide to the South African Competition Commission in January 2023. The CompCom confirmed their intention to investigate this case in February 2023. Appendix A, 2024-02-06, Tbls...
Sa’s Medicine Patent Laws Must Be Changed
– INTERVIEW SALOME MEYER https://youtu.be/IygOCleU1Z4 SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of breast cancer.
Gauteng’s Oncology Crisis
https://www.youtube.com/watch?v=y6KaJ6q2-p4 It’s a story often repeated in South Africa’s neglected public healthcare system: old equipment, untrained staff, and a general lack of resources. In...
CANCER SERVICES UNDER THREAT IN SOUTH AFRICA
National Department of Health is silent on the cancer crisis! Cervical Cancer Patient Story - Ziphora Ziphora Tau, 56, is a mother of two from the North West who is currently living in Vogelstruisfontein with her daughter and grandchild. In September 2019, she was diagnosed with cervical cancer at...
MAVERICK CITIZEN: HEALTH Dying for Treatment: The struggle for affordable breast cancer medicines in South Africa
Across the world, October is marked as breast cancer month. It is an opportunity to create awareness, educate people and provide support for breast cancer survivors and those close to them. In South Africa, more than 10 dedicated breast cancer organisations do their bit. No other single cancer in...
SA’S MEDICINE PATENT LAWS MUST BE CHANGED
– INTERVIEW SALOME MEYER https://youtu.be/IygOCleU1Z4 SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of breast cancer.
Categories
PATIENT GROUPS WELCOME RELEASE OF DRAFT INTELLECTUAL PROPERTY POLICY
Patient groups welcome release of Draft Intellectual Property Policy JOHANNESBURG, 14th AUGUST 2017 – On 8 August 2017, the Department of Trade and Industry published the Draft Intellectual Property Policy of the Republic of South Africa, Phase I,...
VISION CANCER NEWSLETTER – JULY 2017
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter July 2017 National shortage of essential cancer drug Betanoid - AMA-GROOTMAN promoting healthy relationships - CancerCare Outeniqua celebrate International Cancer Survivors...
17TH WORLD CONFERENCE ON TOBACCO OR HEALTH (WCTOH) NOW ACCEPTING SESSION PROPOSALS, ABSTRACTS AND REGISTRATIONS
17th World Conference on Tobacco or Health: Submissions and Registration Open The 17th World Conference on Tobacco or Health (WCTOH) is now accepting session proposals, abstracts and registrations. WCTOH will be held from 7-9 March 2018...
SA’S MEDICINE PATENT LAWS MUST BE CHANGED
– INTERVIEW SALOME MEYER https://youtu.be/IygOCleU1Z4 SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of...
SAHRC ACTS TO PROTECT CANCER PATIENT’S RIGHTS TO ADEQUATE HEALTHCARE
The media statement below was issued by the South Africa Human Rights Commission on 15th June 2017. The full report entitled Investigative Report - Dr Imran Keeka, DA, MPL vs Addington Hospital & 3 others, KwaZulu Natal, Complaint File Ref:...
SA’S MEDICINE PATENT LAWS MUST BE CHANGED – INTERVIEW SALOME MEYER
SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of breast cancer. Watch the interview here.
VISION CANCER NEWSLETTER – JUNE 2017
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter June 2017 Durban’s last public sector oncologist leaves - Major global research funders take lead on clinical trial transparency - Cancer Alliance Advocacy Toolkit Priority area #2 :...
COST OF CANCER TREATMENT IN SA – INTERVIEW PROF MICHAEL HERBST
Prof Michael Herbst of CANSA was interviewed on SABC TV on the question of the exorbitant costs of cancer medications and the announcement by the Competition Commission of its probe into the pricing of several cancer medicines in South Africa....
COST OF CANCER TREATMENT IN SA – INTERVIEW PROF MICHAEL HERBST
Prof Michael Herbst of CANSA was interviewed on SABC TV on the question of the exorbitant costs of cancer medications and the announcement by the Competition Commission of its probe into the pricing of several cancer medicines in South Africa.
FTPL COALITION WELCOMES COMPETITION COMMISSION PROBE INTO CANCER MEDICINES
FTPL Coalition welcomes landmark Competition Commission probe into prices of cancer medicines JOHANNESBURG, 13 JUNE 2017: The Fix the Patent Laws coalition welcomes the Competition Commission’s announcement earlier today that they will...
COMPETITION COMMISSION ANNOUNCES INVESTIGATION INTO VARIOUS DRUGS FOR CANCER
The Competition Commission of South Africa Media For immediate release 13 June 2017 MEDIA STATEMENT BY THE COMMISSIONER ON THE INVESTIGATION INTO MANUFACTURERS OF CANCER DRUGS Good afternoon ladies and gentlemen of the media. As you may be aware,...
VISION CANCER NEWSLETTER – MAY 2017
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter May 2017 WHO to begin pilot prequalification of biosimilars -2nd Annual World Pancreatic Cancer Coalition Meeting - Pelvic radiation and its complications - Cancer Alliance Advocacy...